VarCT Diagnostics ApS: Financial statements 2018
CVR: 38733567
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
VarCT Diagnostics ApS (CVR 38733567) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -472,235 and a net result of DKK -1,767,180. Equity in the 2018 report amounted to DKK 12,724,403. The solvency ratio was 89.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -472,235
- Profit/Loss
- DKK -1,767,180
- Equity
- DKK 12,724,403
- Total Assets
- DKK 14,181,822
- Employees
- 2
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of June 15, 2018, VAR2 PHARMACEUTICALS ApS is registered as an owner of VarCT Diagnostics ApS with an ownership share of 66%.
As of June 15, 2018, is registered as an owner of VarCT Diagnostics ApS with an ownership share of 20%.
VarCT Diagnostics ApS has published its interim report for the period June 20, 2017 – December 31, 2017.
As of January 18, 2018, Ulf Andreas Linderoth Norlin is registered as director of VarCT Diagnostics ApS.
About VarCT Diagnostics ApS
VarCT Diagnostics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The board consists of Mads Daugaard (chair), Ali El-Salanti, Josef Rainer and Peter Schröcksnadel. The company is owned by VAR2 PHARMACEUTICALS ApS and Sitour Management m.b.H.. The company has 4 employees (2018). In 2025, the company reported a gross profit of DKK 176,862 and a net result of DKK -1,961,493 compared with DKK 779,245 the year before. Equity in the 2025 report amounted to DKK 2,238,264.